(+)-Arisugacin A—Computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase

(+)-Arisugacin A—Computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors:  New Disease-Modifying Agents for Alzheimer's Disease From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase Design and synthesis of thienopyridines as novel templates for acetylcholinesterase inhibitors Chiral Separation, X-ray Structure, and Biological Evaluation of a Potent and Reversible Dual Binding Site AChE Inhibitor Additional acetyl cholinesterase inhibitory property of diaryl pyrazoline derivatives Structure−Activity Relationships of Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone. 4. Further Investigation on the Inner Spacer 3-(4-{[Benzyl(methyl)amino]methyl}phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) Inhibits Both Acetylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation:  A Dual Function Lead for Alzheimer's Disease Therapy